The expression and role of tyrosine kinase ETK/BMX in renal cell carcinoma

被引：0
作者：
Jintao Zhuang
Xiangan Tu
Kaiyuan Cao
Shengjie Guo
Xiaopeng Mao
Jincheng Pan
Bin Huang
Xu Chen
Yong Gao
Shaopeng Qiu
机构：
[1] Sun Yat-sen University,Department of Urology, The First Affiliated Hospital
[2] Sun Yat-sen University,Research Center for Clinical Laboratory Standard, Zhongshan Medical School
[3] Sun Yat-sen University Cancer Center,Department of Urology
来源：
Journal of Experimental & Clinical Cancer Research | / 33卷
关键词：
Renal cell carcinoma; ETK; Small interfering RNA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Clinical management of patients receiving tyrosine kinase inhibitors for advanced renal cell carcinoma
    Roigas, Jan
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (09) : 593 - 600
  • [32] Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma-Future or the Past?
    Michaelis, Jakob
    Grabbert, Markus
    Sigle, August
    Yilmaz, Mehmet
    Schlager, Daniel
    Gratzke, Christian
    Miernik, Arkadiusz
    Schoeb, Dominik Stefan
    CANCERS, 2022, 14 (15)
  • [33] Adjuvant tyrosine kinase inhibitors for renal cell carcinoma? No, thank you (at least for the present)
    Leonetti, Alessandro
    Zielli, Teresa
    Buti, Sebastiano
    FUTURE ONCOLOGY, 2018, 14 (22) : 2223 - 2224
  • [34] Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma
    Stuhler, Viktoria
    Rausch, Steffen
    Maas, Jan Moritz
    Stenzl, Arnulf
    Bedke, Jens
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (09) : 1215 - 1226
  • [35] Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma
    Miller, Jacob A.
    Balagamwala, Ehsan H.
    Angelov, Lilyana
    Suh, John H.
    Rini, Brian
    Garcia, Jorge A.
    Ahluwalia, Manmeet
    Chao, Samuel T.
    JOURNAL OF NEUROSURGERY-SPINE, 2016, 25 (06) : 766 - 774
  • [36] Expression Analysis of Tyrosine Phosphatase Genes at Different Stages of Renal Cell Carcinoma
    Laczmanska, Izabela
    Laczmanski, Lukasz
    Sasiadek, Maria M.
    ANTICANCER RESEARCH, 2020, 40 (10) : 5667 - 5671
  • [37] Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
    Catalano, Martina
    De Giorgi, Ugo
    Maruzzo, Marco
    Bimbatti, Davide
    Buti, Sebastiano
    Mazzaschi, Giulia
    Procopio, Giuseppe
    Santoni, Matteo
    Galli, Luca
    Conca, Raffaele
    Doni, Laura
    Antonuzzo, Lorenzo
    Roviello, Giandomenico
    BIOMEDICINES, 2022, 10 (10)
  • [38] The prognostic significance of CDK6 expression in renal cell carcinoma treated by immune checkpoint plus tyrosine kinase inhibition
    Wang, Jiajun
    Zhang, Sihong
    Wang, Ying
    Zhu, Yanjun
    Xu, Xianglai
    Guo, Jianming
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2023, 98 (04)
  • [39] Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 Expression
    Xu, Xianglai
    Wang, Ying
    Chen, Zhaoyi
    Zhu, Yanjun
    Wang, Jiajun
    Guo, Jianming
    CANCER RESEARCH AND TREATMENT, 2023, 55 (04): : 1321 - 1336
  • [40] Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma
    Wang, Jiajun
    Xu, Xianglai
    Wang, Ying
    Zhu, Yanjun
    CELLULAR ONCOLOGY, 2025, : 775 - 787
12345